SEARCH Articles Figures Tables A common design in therapeutic exploratory and confirmatory trials ADR Detection in Clinical Trials AIDS vaccines in clinical trials Additional statistical considerations in clinical trials Allocating Treatments to Patients in Clinical Trials Allocolchicinoids in clinical trials Authorisation of Clinical Trials in the US Central Principles of Experimental Design in Clinical Trials Clinical Trials in The US Clinical Trials in the EU Clinical trials in children Compliance in clinical trials Concluding comments on safety assessments in clinical trials Control group in clinical trials Control in clinical trials Deaths in clinical trials Defibrillation in acute myocardial infarction trial Defibrillator in acute myocardial infarction trial Eli Lilly Hides Increased Suicidality on Prozac in Controlled Clinical Trials Endpoints and markers in clinical trials Ethics in clinical trials First-in-human clinical trials First-in-human trials Fraud in clinical trials Gas spike surveys and wells in trial pits In vivo preclinical model trial In-situ trial Interim Analyses in Group Sequential Trials Methodology to minimize bias in open-label trials No Completed Suicides in the Clinical Trials Non-protein inhibitors in clinical trials Other issues in making trials effective Pharmacoeconomics in clinical trials Primary angioplasty in myocardial infarction trial Study Design in Drug Clinical Trials Sudden cardiac death in heart failure trial Surrogate End Points in Clinical Trials of ACE Inhibition Are We Being Misled Target Identification and Validation Clinical Trial in a Dish The rationale for safety assessments in clinical trials The relationship between hypothesis testing and ethics in clinical trials The role of clinical trials in new drug development Thrombolysis in Myocardial Infarction trial Valiolamines in clinical trials Valsartan in acute myocardial infarction trial Valsartan in acute myocardial infarction trial VALIANT)